Investor Presentaiton
Q2 2023 Financial Review
//Andlauer
HEALTHCARE
Year-over-year decline in revenue primarily reflects superior U.S. ground transportation rate premiums, higher revenue
related to COVID-19 vaccines and ancillary products, higher fuel surcharges and unusually high air freight forwarding
volumes in Q2 2022.
GROUP
~0.8% of revenue generated from distribution of COVID vaccines and ancillary products, compared to ~ 2.6% in Q2 2022.
Three months ended
Three months ended
(In 000's, except percentages)
Revenue
Logistics and Distribution
Packaging
Healthcare Logistics Segment
Ground Transportation
June 30, 2023
June 30, 2022
Change
$ 39,438
$ 41,845
(5.8)%
4,236
6,164
(31.3)%
43,674
48,009
(9.0)%
103,451
106,332
(2.7)%
Air Freight Forwarding
7,678
11,534
(33.4)%
Dedicated and Last Mile Delivery
16,339
17,117
(4.5)%
Less: Intersegment Eliminations
(13,785)
(13,590)
1.4%
Specialized Transportation Segment
Total Revenue
113,683
121,393
(6.4)%
$ 157,357
$ 169,402
(7.1)%
16View entire presentation